Form D · Pharmaceuticals
ApoVax, Inc.
Loisville, KY · CIK 0001329338
Offering snapshot reported Nov 26, 2012 · SEC filing
- Reported sold
- $125K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 13, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 26, 2012 | Initial | $125,000 | No comparison | 1 | SEC filing |
| Dec 7, 2011 | Initial | $250,000 | No comparison | 2 | SEC filing |
| Jan 28, 2011 | Initial | $25,196 | No comparison | 1 | SEC filing |
| May 31, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-187427
Source: Form D, filed Nov 26, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael J. Curtin | Director |
| George Emont | Director, Executive |
| Steven R. Gailar | Director, Executive |
| Haval Shirwan | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1044 East Chestnut St
Loisville, KY, 40204
Loisville, KY, 40204